Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers V > Headlines for Ventiv Health Inc. > News item |
Ventive price target raised by Jefferies
Ventive Health Inc. was maintained by Jefferies & Co. analyst David Windley at a buy rating and the price target on the stock was raised to $29 per share from $28 following second-quarter results. Ventive shares Tuesday were down $0.29, or 1.20%, at $23.90 on volume of 530,626 shares versus the three-month running average of 529,425 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.